Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Pandoraon Feb 22, 2023 4:38pm
68 Views
Post# 35299357

RE:RE:Talk about shaking a tree.Being a nice clean up day $

RE:RE:Talk about shaking a tree.Being a nice clean up day $
In that last item of your list it refers to "without a response from the Company" -- that is the cart before the horse.

The Company was the one that withdrew from the program.

After seeing the negative reaction a couple months back when NICE put out a news item suggesting a poor performance by the Company device the Company knew (or should have) that this news from NICE would also cause a negative reaction. I would suggest it was incumbent on the Company to get out in front of NICE with a news item of explanation, ie. not having to be in a position of having to respond -- which thus far we still have not received.

What will the logic be, if and when we receive such news. Luckily we are only down 3 cents -- but what happens tomorrow if there is no rationale.
<< Previous
Bullboard Posts
Next >>